Table-2.

Recent combinatorial autophagic inhibitors with other drugs in Clinical Trials.

Combinatorial Drug	Cancer	Clinical Phase
HCQ + everolimus [170]	Advanced clear cell renal cell carcinoma	I/II
HCQ + tamoxifen [170]	Breast cancer	I
HCQ + vorinostat [159,170]	Malignant solid tumor, Colorectal cancer	I/II
HCQ + gemcitabine [159]	Advanced adenocarcinoma, small cell lung cancer	I/II
HCQ + Sunitinib malate [159,170]	Adult solid neoplasm	I
HCQ [159]	ER + Breast Cancer, Prostate Cancer	I/II
HCQ + Abraxane and gemcitabine [159]	Pancreatic carcinoma	II
HQ + Dabrafenib and Trametinib [170]	Low grade and high-grade gliomas	I/II
CQ with concurrent chemoradiation + Temozolomide [170]	Glioblastoma, GBM	I
CQ + bortezomib [170]	Hematologic malignancy	.